The shakeup at Boston Scientific (NYSE:BSX) last week proved that while the sheriff may be headed for the sunset, he’s not ready to hang up his spurs just yet. With little more than a month past his two year anniversary of taking the helm at BSX, J. Raymond Elliott continues to re-shape the Natick, Mass.-based […]
Repealing the medical device tax is the most critical issue to maintaining a “climate of innovation,” Boston Scientific Corp. (NYSE:BSX) CEO J. Raymond Elliott wrote in a July 4th editorial for Star Tribune newspaper. “The medical device tax directly undermines the Obama administration’s competitiveness agenda. It will remove an estimated $20 billion from the private […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com. This week's life science current events include Ray Elliott and Boston Scientific's new CEO, "Obamacare" and insurance agents, and Medtronic diabetes cuts.
J. Raymond Elliott’s decision to step down as CEO of Boston Scientific (NYSE:BSX) began a little more than a month ago, when the company’s board asked him to document the accomplishments of his two-year tenure. As he spent an entire Sunday on a detailed outline of the past and — more importantly — the future […]
News that Boston Scientific Corp. (NYSE:BSX) is looking for a new CEO now that Ray Elliott plans to hang up his spurs at the end of the year shocked Wall Street, where BSX shares plunged nearly 9 percent on the day. The Natick, Mass.-based medical device maker said its corner office will be empty as […]
Boston Scientific Corp. (NYSE:BSX) is looking for a new CEO, after J. Raymond Elliott announced he will be retiring at the end of the year. Elliott, 61, said his retirement from the Natick, Mass.-based medical device maker will be effective as of December 31, 2011. Company officials said BSX has appointed a special search committee […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.